Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
CLOV Transcript
Clover Health Investments, Corp. (CLOV) Q1 2026 Earnings Call Transcript
Positive5-7
The financial performance shows positive trends with a 15% revenue increase, improved Medical Care Ratio, and reduced net loss, indicating stronger financial health. Adjusted EBITDA turning positive is a significant improvement. The strategic plan for 2026 and beyond highlights growth and profitability targets, further supporting a positive outlook. Despite risks and uncertainties, the overall sentiment leans towards optimism, suggesting a likely positive stock price movement.
Clover Health Investments, Corp. (CLOV) Q4 2025 Earnings Call Transcript
Positive2-26
The company demonstrated strong financial performance with a 41% increase in insurance revenue and full-year adjusted EBITDA profitability. Membership growth and controlled medical cost trends contributed to a 40% increase in total revenue. Despite a slight decline in gross profit margin, the profitability of new cohorts is expected to improve. The strategic focus on expanding the Clover Assistant and Counterpart Health, along with disciplined cost management, supports a positive outlook. However, management's lack of specific guidance for certain initiatives and lowered 2025 EBITDA guidance temper the overall sentiment.
Clover Health Investments, Corp. (CLOV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral1-15
Clover Health Investments, Corp. (CLOV) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Neutral12-4
CLOV Slides
CLOV Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
